(Q45988832)

English

Tomatidine acts in synergy with aminoglycoside antibiotics against multiresistant Staphylococcus aureus and prevents virulence gene expression.

scientific article published on 30 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

Tomatidine acts in synergy with aminoglycoside antibiotics against multiresistant Staphylococcus aureus and prevents virulence gene expression. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

multiple drug resistance

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

Francois Malouin

9

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

author name string

Gabriel Mitchell

1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

Myriame Lafrance

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

Simon Boulanger

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

David Lalonde Séguin

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

Isabelle Guay

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

Mariza Gattuso

6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

Eric Marsault

7

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

Kamal Bouarab

8

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

language of work or name

0 references

publication date

30 November 2011

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

67

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

559-568

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Staphylococcus aureus: a well-armed pathogen

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Regulatory and genomic plasticity of Staphylococcus aureus during persistent colonization and infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Lung infections associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Waves of resistance: Staphylococcus aureus in the antibiotic era.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Meticillin-resistant Staphylococcus aureus in animals: a review

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Autoinduction and signal transduction in the regulation of staphylococcal virulence

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Quorum sensing in staphylococci

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Plant antimicrobial agents and their effects on plant and human pathogens

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Tomatidine inhibits replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cells

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Response of Staphylococcus aureus isolates from bovine mastitis to exogenous iron sources

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Transcriptional modulation of some Staphylococcus aureus iron-regulated genes during growth in vitro and in a tissue cage model in vivo

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Contributions of the AmpC beta-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to beta-lactams

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Aminoglycoside modifying enzymes

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Single and Combination Antibiotic Therapy of Staphylococcus aureus Experimental Endocarditis: Emergence of Gentamicin-Resistant Mutants

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Selection and characterization of strains of Staphylococcus aureus displaying unusual resistance to aminoglycosides

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Back to the future: using aminoglycosides again and how to dose them optimally

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Aminoglycoside use in cystic fibrosis: therapeutic strategies and toxicity.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Do we still need the aminoglycosides?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Rational design of a global inhibitor of the virulence response in Staphylococcus aureus, based in part on localization of the site of inhibition to the receptor-histidine kinase, AgrC

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKR510

21 January 2018

Identifiers

10.1093/JAC/DKR510

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/22129590

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45988832&oldid=1387853091"